IRIS
BREVETTI, GREGORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 988
EU - Europa 483
AS - Asia 273
AF - Africa 7
OC - Oceania 1
SA - Sud America 1
Totale 1.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 976
SG - Singapore 155
UA - Ucraina 143
CN - Cina 111
IT - Italia 96
FI - Finlandia 54
DE - Germania 53
NL - Olanda 47
SE - Svezia 34
GB - Regno Unito 23
IE - Irlanda 19
CA - Canada 12
FR - Francia 10
CI - Costa d'Avorio 7
IR - Iran 3
CZ - Repubblica Ceca 2
ES - Italia 2
TR - Turchia 2
AM - Armenia 1
AR - Argentina 1
IN - India 1
NZ - Nuova Zelanda 1
Totale 1.753
Salva come PNG Salva come JPEG
Città #
Chandler 199
Jacksonville 164
Singapore 135
Santa Clara 61
Princeton 52
Amsterdam 44
Boston 43
Millbury 40
Beijing 34
Wilmington 33
Nanjing 30
Boardman 11
Nanchang 11
Houston 10
Ashburn 9
Kronberg 9
Ottawa 9
Falls Church 8
Hebei 8
Campobasso 7
Los Angeles 6
Naples 6
Norwalk 6
Kunming 5
Napoli 5
Shenyang 5
Tianjin 5
Jiaxing 4
Orange 4
Changsha 3
San Mateo 3
Cologno Monzese 2
Dearborn 2
Fontenay-aux-Roses 2
Munich 2
Prineville 2
Redmond 2
Toronto 2
Ann Arbor 1
Ardabil 1
Auckland 1
Augusta 1
Avellino 1
Baltimore 1
Beverley 1
Brno 1
Changchun 1
Cixi 1
Cologne 1
Cornwall 1
Dobra 1
Dublin 1
Eindhoven 1
Frankfurt am Main 1
Gallatin 1
Helsinki 1
Jinhua 1
Lappeenranta 1
Madrid 1
Nocera Superiore 1
Pilar 1
Pune 1
Tappahannock 1
Walnut 1
Washington 1
Yerevan 1
Totale 1.011
Salva come PNG Salva come JPEG
Nome #
Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease? 55
The treatment with growth hormone receptor antagonist in acromegaly: effect on vascular structure and function in patients resistant to somatostatin analogues. 53
Adhesion molecules and cardiovascular risk in peripheral arterial disease. Soluble vascular cell adhesion molecule-1 improves risk stratification 50
Effect of propionylcarnitine on changes in endothelial function and plasma levels of adhesion molecules induced by acute exercise in patients with intermittent claudication 50
Aortic valve sclerosis in patients with peripheral and/or coronary arterial disease. 50
Cellular adhesion molecules and peripheral arterial disease 49
Functional status measured by walking impairment questionnaire and cardiovascular risk prediction in peripheral arterial disease: results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 49
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease. 48
Peripheral arterial disease: the magnitude of the problem and its socioeconomic impact. 47
Exercise increases soluble adhesion molecules ICAM-1 and VCAM-1 in patients with intermitent claudication 46
Metabolic syndrome in peripheral arterial disease: relationship with severity of peripheral circulatory insufficiency, inflammatory status, and cardiovascular comorbidity. 46
Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index 44
Carnitine-related alterations in patients with intermittent claudication. Indication for a focused carnitine therapy 43
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not with classic risk factors and atheroscloritic burden 40
EUROPEAN MULTICENTER STUDY ON PROPIONYL-L-CARNITINE IN INTERMITTENT CLAUDICATION 39
Peripheral arterial disease and cardiovascular risk in Italy. Results of the Peripheral Arteriopathy and Cardiovascular Events (PACE) study 36
Effects of Ile164 polymorphism of beta2-adrenergic receptor gene on coronary artery disease. 36
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb. 36
Inflammatory status and endothelial function in asymptomatic and symptomatic peripheral arterial disease. 35
Early vascular alterations in acromegaly 35
Effects of AT1 receptor antagonism with candesartan on endothelial function in patients with hypertension and coronary artery disease. 35
Relationship between brachial artery flow-mediated dilation and coronary flow reserve in patients with peripheral artery disease 35
Microcirculation and tissue metabolism in peripheral arterial disase 34
Increased inflammatory status and higher prevalence of three-vessel coronary artery disease in patients with concomitant coronary and peripheral atherosclerosis 34
Intermittent claudication in Italy. The Peripheral Arteriopathy and Cardiovascular Events (PACE) study 33
EARLY VASCULAR ALTERATIONS IN ACROMEGALY 33
L’IMPIANTO DI STENT NELLE ARTERIE DEGLI ARTI INFERIORI RIDUCE IL RISCHIO CARDIOVASCOLARE IN PAZIENTI CON ATEROSCLEROSI PLURIDISTRETTUALE. 33
Metabolic syndrome and cardiovascolar risk prediction in peripheral arterial disease. 33
High Levels of adhesion molecules are associated with impaired endothelium-mediated vasodilation in patients with peripheral arterial disease 32
MUSCLE CARNITINE DEFICIENCY IN PATIENTS WITH SEVERE PERIPHERAL VASCULAR DISEASE 31
Intermittent claudication and endothelial dysfunction 31
Intermittent claudication in older patients: risk factors, cardiovascular comorbidity, and severity of peripheral arterial disease 30
Intermittent Claudication. Pharmacoeconomic and Quality of life aspects of treatment 30
Intermittent claudication: an historical perspective 30
Mortality in peripheral arterial disease: a comparison of patients managed by vascular specialists and general practitioners. 30
The impact of comorbidity burden on the cardiovascular risk in the Peripheral Arteriopathy and Cardiovascular Events (PACE) study. 30
IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb 30
Effective treatment of orthostatic hypotension by propranolol in the Shy-Drager syndrome. 30
Infrarenal abdominal aortic aneurysms 29
Echolucent femoral plaques entail higher risk of echolucent carotid plaques and a more severe inflammatory profile in peripheral arterial disease. 29
Vitamin C prevents endothelial dysfunction induced by acute exercise in patients with intermittent claudication 27
Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose-titration, multicenter study 27
Statin therapy in patients with subclinical and evident peripheral artery disease: a meta-analysis 25
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. 24
Myeloperoxidase, but not C-reactive protein, predicts cardiovascular risk in peripheral arterial disease 24
Stent implantation in the arteries of the lower limbs reduces cardiovascular risk in peripheral arterial disease. 24
Prevalence of hypoechoic carotid plaques in coronary artery disease: relationship with coexistent peripheral arterial disease and leukocyte number 23
In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction. 22
The prevalence of hypoechoic carotid plaques is greater in peripheral than in coronary artery disease and is related to the neutrophil count 20
Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function 19
Relationship between insulin-like growth factor-1 system and exercise tolerance in patients with intermittent claudication. 17
Women and peripheral arterial disease: same disease, different issues 15
Totale 1.786
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020116 0 0 0 0 30 4 0 1 0 21 19 41
2020/2021275 5 31 33 30 31 42 30 0 34 3 36 0
2021/2022251 3 0 0 2 2 6 8 8 25 9 72 116
2022/2023452 58 57 8 45 37 44 52 29 61 46 12 3
2023/2024192 6 48 29 11 8 10 0 17 4 8 32 19
2024/2025231 73 69 1 8 80 0 0 0 0 0 0 0
Totale 1.786